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Purpose: An investigation of the antimicrobial susceptibility patterns of Staphylococcus aureus isolated 
from healthy women to ten commonly used antimicrobial drugs was carried out as a basis for a guide for 
empirical antimicrobial treatment using urine samples.  
Method: The samples collected from healthy women volunteers in Zaria were cultured and screened for 
S. aureus using standard microbiological procedures. The antimicrobial susceptibility of the isolates was 
investigated using disc diffusion technique.  
Result: A total of 54(36%) S. aureus isolates were isolated from 150 urine samples collected. Of the 54 
isolates, 16 (29.6%), 15 (27.8%) and 23 (42.6%) were from married but not pregnant, pregnant and 
single women respectively. The isolates were highly susceptible to ciprofloxacin, gentamicin, ofloxacin, 
sparfloxacin and pefloxacin in both groups (married and single). The differences observed in all the 
antimicrobial drugs tested for both groups were not statistically significant (p>0.05). A total of 34 (63%) 
of the isolates showed multi-drug resistance and only 6 (11%) were susceptible to all the antimicrobial 
drugs tested.  
Conclusion: This observation calls for measures to reduce the reservoir of antimicrobial resistant 
organisms in healthy populations. 
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INTRODUCTION 
 
Staphylococcus aureus is a worldwide 
pathogen with its natural reservoir in human. It 
is one of the most common causes of severe 
community associated infections of skin and 
soft tissue1, 2. Treatment of serious S. aureus 
infections can be challenging, and the 
associated mortality rate remains 20% to 25% 
despite the availability of highly active 
antimicrobial drugs 3. 
 
S. aureus colonises the nares, axillae, vagina 
and damaged skin surfaces. About 30% to 
50% of healthy adults are colonised with 10 to 
20% persistently colonised 4. Approximately 
60% of women harbour this organism 
intermittently at one or more body sites 5. 
Studies have shown that 7-25% of women 
harbour toxin-producing S. aureus 6. Persons 
colonised with S. aureus strains are at 
increased risk of becoming infected with these 
strains 1, 7. 
  
In the early 1950s, penicillinase-producing 
strains were universally present in hospital 
while community-associated isolates of S. 
aureus were considered to be largely penicillin 
susceptible. However, over the past few 
years, community-associated S. aureus 
infections are not only resistant to penicillin 
but to all other β- lactam antibiotics 8, 9. More 
so, it is known that epidemic strains of S. 
aureus are commonly resistant to many 
antimicrobial drugs thereby making the choice 
of appropriate therapy difficult. 
 
We hereby report the antimicrobial 
susceptibility pattern of community associated 
S. aureus isolated from healthy women in 
Zaria community as guide for empirical 
antimicrobial treatment and a basis for their 
reduction in healthy communities. This is 
relevant since resistance is believed to be a 
common phenomenon among strains of this 
organism, which is a likely result of 
indiscriminate use of antimicrobial drugs, a 
common occurrence in most Nigerian 
communities.  
MATERIALS AND METHODS 
Sample Collection 
First “clean catch” urine samples were 
collected randomly from 150 healthy women 
of three (3) categories (single, married but not 
pregnant, and pregnant women of ages 
between 20-40 years) over a period of two (2) 
months from Zaria community after informed 
consent had been obtained from each woman. 
All the volunteers were not on any 
antimicrobial drug at the point of sampling. 
Samples (Fifty from each group) were 
collected into labelled sterile bottles, kept in 
an iced-bag and transported to the laboratory. 
Bacteriology 
Within two (2) hours of collection, each urine 
sample was inoculated (in duplicates) into 
Mannitol salt agar plates on arrival at the 
laboratory. The plates were incubated 
aerobically at 37OC for 24 hours. The 
characteristic isolates were identified using 
colonial, morphological and biochemical 
characteristics as described by Cheesbrough 
10
. Isolates that were Gram-positive cocci, 
catalase positive and coagulated human 
plasma were considered as S. aureus in this 
study.  
 
Definition of Community-associated 
Isolates 
For the purpose of this study, community-
associated isolates were defined as isolates 
from the samples of the healthy women who 
were not on any antimicrobial drug at the time 
of sampling and had not been admitted in 
hospital in the last one year. 
Antimicrobial Susceptibility testing 
Antimicrobial susceptibility pattern of all 
isolated S. aureus to the following ten (10) 
commonly used antimicrobial drugs in the 
community [ampicillin 10µg (Medreich sterilab, 
India), cephalexin 30µg (Fidson, India), 
ciprofloxacin (ciprotab®) 5µg (Fidson, India), 
clindamycin (Dalacin C®) 2µg (Pharmacia, 
Belgium), gentamicin (Hefogenta®) 10µg 
(Wuham, china), methicillin 10µg (Oxoid, UK), 
ofloxacin (Fluxor®) 5µg (Pathoteq Lab, India), 
pefloxacin (Peflotab®) 5µg (Fidson, India), 
Sparfloxacin (Sparbact®) 5µg (Pathoteq Lab. 
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India) and vancomycin 30µg (Dumex-
Alpharma, S. Demark)] were determined by 
the modified Kirby-Bauer diffusion technique 
10. Standardised overweight culture of each 
isolates (containing about 108 cfu/ml) was 
used to flood the surface of Mueller Hinton 
agar (MHA) plates; the excess was drained off 
and the surface was allowed to dry 
aseptically. The standard antimicrobial discs 
were then aseptically placed at reasonable 
equidistance on the inoculated MHA plates 
and allowed to stand for 1hour. The plates 
(prepared in duplicate for each isolate) were 
then incubated at 37OC for 18 hours 7. The 
diameter of the zone of inhibition produced by 
each antimicrobial disc was measured, 
recorded and isolates were classified as 
“resistant”, “intermediate sensitive” or 
sensitive (susceptible) based on the standard 
interpretative chart updated according to the 
current the National Committee for Clinical 
Laboratory standards (NCCLS; now the 
Clinical and Laboratory Standards Institute 
[CLSI] guidelines 11.  
Statistical Analysis 
Frequencies were obtained and percentages 
were calculated for study variables. Chi-
square and two tailed Fisher’s exact test were 
used to calculate probabilities and determine 
significance. A p-value of less than or equal to 




Fifty-four (36%) out of 150 urine samples of 
healthy women volunteers screened yielded 
S. aureus isolates. The distribution of S. 
aureus isolates among the groups of women 
showed that it is more prevalent in the singles 
than the two groups of married women (Table 
1). 
 
The antimicrobial susceptibility test results in 
Table 2 show that the isolates from all the 
groups were generally highly susceptible to 
ciprofloxacin, gentamicin, ofloxacin, pefloxacin 
and sparfloxacin. They have generally very 
low susceptibility to ampicillin, cephalexin, 
clindamycin, methicillin and vancomycin. The 
observed differences in the susceptibility of 
the isolates from the two groups of women to 
the tested antimicrobial drugs is not 
statistically significant (p>0.05). 
 
Multi-drug resistance in this study was taken 
as resistance to four or more of the ten 
antimicrobial drugs tested. The results 
showed 34 (63%) of the isolates as multi-drug 
resistant and were methicillin resistant 
Staphylococcus aureus (MRSA). Only 6 (11%) 
of the isolates were fully susceptible to all the 
tested antimicrobial drugs. The distribution of 
prevalence of multi-drug resistant S. aureus is 
shown in Figure 1.   
 
DISCUSSION 
S. aureus is a virulent organism that is 
renowned for its potential to acquire 
resistance to antimicrobial agents and it is one 
of the common cause of community-acquired 
and nosocomial infections 3. 
  
Analysis of the healthy women urine in this 
study gave a total prevalence rate of 36%, 
which supported previous reports of studies 
carried out in Zaria 8 and Abuja 9. This result 
points to the increasing importance of this 
organism as a urinary pathogen and genital 
colonizers in our society. It may equally infer 
correspondingly high prevalence in healthy 
children and men because of the role of 
women (as mothers and wives) in our society. 
Further, broader based studies should be 
carried out to ascertain this postulation. The 
difference in the colonization rate of S. aureus 
in the married and single women was not 
significant (p>0.05) indicating that marital 
status is not a notable factor in colonization 
and there is no activity or behaviour of any of 
the groups, which predisposes them to S. 
aureus infection.  
 
As expected the highest antimicrobial 
resistance was observed in ampicillin (77%) in 
both groups. This continuing upward trend has 
been noted in other studies 8, 9, 12. Resistance 
to cephalexin and clindamycin is in conformity 
with previous observations that most isolates 
of S. aureus are resistant to large number of 
commonly prescribed antibiotics 13. The low 
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susceptibility observed in methicillin and  
Table 1: Frequency of isolation of Staphylococcus aureus from the three groups of women 
tested. 
 
  Source  Number of   Presence of S. aureus 
    Samples   no (%) 
  Married      50    16 (32) 
  Pregnant     50    15 (30) 
  Single      50    23 (46) 
  Total    150    54 (36) 
 
 
Table 2: Antimicrobial susceptibility profiles of S. aureus isolates from urine samples of the 
women tested. 
 
                                                      Isolates sensitive to antimicrobial drugs 
Antimicrobial drugs  *Married  Single          
    N = 31   N = 23 
   no (%)  no (%)  P-value 
Ampicillin 10µg   4 (12.9)  3 (13.0)  1.0 
Cephalexin 30µg   10 (32.3)  7 (30.0)  1.0 
Ciprofloxacin 5µg   24 (77.4)  19 (82.6)  0.741 
Clindamycin 2µg   5 (16.1)  9 (39.1)  0.068 
Gentamicin 10µg   26 (83.9)  22 (95.7)  0.224 
Methicillin 10µg   10 (32.3)  7 (30.4)  1.0 
Ofloxacin 5µg   24 (77.4)  19 (82.6)  0.741 
Pefloxacin 5µg    24 (77.4)  16 (69.6)  0.546 
Sparfloxacin 5µg   25 (80.6)  20 (87.0)  0.717 
Vancomycin 30µg  9 (29.0)  9 (39.1)  0.561 
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Figure 1: Distribution of prevalence of multi-drug resistant Staphylococcus aureus 
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vancomycin (30-40%) in the two groups 
support the previous reports in our 
communities 14, 15. The resistance may be due 
to the acquisition of resistance determining 
genes, such as mecA (methicillin), van A, B, C 
responsible for vancomycin resistance in 
enterococci 16, 17 or as a result of the 
thickening of the cell wall as reported by some 
authors 17, 18. These were however not 
determined in this work. A total of 70-96% of 
the isolates was highly susceptible to 
gentamicin, ofloxacin, ciprofloxacin, 
sparfloxacin and pefloxacin in both groups. 
This has been widely reported in most other 
studies 8, 9, 12. Susceptibility to gentamicin 
(through a cheap drug) might be due to the 
route of administration which hinder its 
frequent misuse while the high susceptibility 
observed in the fluoroquinolones tested may 
be due to the fact that they are relatively 
expensive and newer antimicrobial drugs, 
therefore less available for abuse.  
 
The community-associated S. aureus isolates 
tested exhibited a high level of multi-drug 
resistance, which calls for great concern. A 
total of 63% of the isolates were multi-
resistant, 89% were resistant to at least one 
antibiotic and only 11% were susceptible to all 
the antimicrobial drugs. These observations 
confirm the postulation that healthy members 
of the community are the highest reservoirs of 
antimicrobial resistant bacteria 19, 20. 
 
CONCLUSION 
The enormous level of use of antimicrobial 
drugs indiscriminately or justifiably has great 
potential for selecting for or enhancing the 
growth of multi-resistant strains. The results 
from this study show the need to reassess 
policies on antimicrobial drugs use within and 
outside the hospital environment. There is 
also the need for regular monitoring of the 
antimicrobial susceptibility status of important 
pathogens so as to ensure the administration 
of an effective antibiotic whenever there is 
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